Outlook Therapeutics (41O.F) Q4 2024 Earnings

27DecConfirmed
Q2 2024
Q3 2024
Q4 2024
-1.42
-1.2
-0.98
-0.75

Details

Expected EPS
-0.7700348471499999
Actual EPS
-0.843524
Surprise EPS
-0.07
Surprise Percent
+9.54%

Description

Outlook Therapeutics (41O.F) has reported earnings of -0.843524 per share for Q4 2024.

0 Comments

Share your thoughts